HNI Corporation
HNI
$49.02
-0.53%
HNI Corporation is a manufacturer and marketer of commercial furnishings and residential hearth products, operating through two reportable segments: Workplace Furnishings (furniture systems, seating, storage, tables, architectural and hospitality products) and Residential Building Products (gas, wood, electric and pellet fireplaces, inserts, stoves, outdoor fire pits and accessories), sold through independent dealers, distributors, eCommerce retailers and wholesalers, with the vast majority of revenue generated in the United States. The company is a scaled, established player in the consolidating contract-furniture and hearth industries rather than a disruptor, with its Workplace Furnishings segment (roughly $1.42 billion of segment revenue versus $175 million for Residential Building Products) serving as the dominant profit and revenue engine alongside a smaller, housing-cycle-sensitive hearth business. The current investor narrative centers on a sharp post-Q1 inflection: after a loss-making fiscal first quarter, HNI delivered sequential margin recovery through Q2 and Q3, with gross margin climbing from 34.6% to 42.6% and net income swinging from -$38.8 million to $90 million, fueling a powerful six-month re-rating in the shares. Debate now hinges on whether that margin recovery is durable against a soft commercial-furniture and housing backdrop, whether the elevated debt load taken on during recent acquisition activity can be deleveraged, and whether the stock's re-rating has run ahead of a business still growing revenue only modestly year over year.…
HNI
HNI Corporation
$49.02
People also watch
Smith & Nephew
SN
Stanley Gibbons
SGI
Mohawk Industries
MHK
Patrick Industries Inc
PATK
Whirlpool Corp.
WHR
Investment Opinion: Should I buy HNI Today?
Rating: Hold (accumulate on weakness). The core thesis is that HNI's Q1-to-Q3 margin and cash-flow inflection is real and the stock is cheap on sales and book, but a 1.33% revenue growth rate, 0.89 debt-to-equity, negative trailing free cash flow of -$70.1 million and a 116% payout ratio mean the re-rating has outrun the fundamentals; with only one analyst covering the name (Benchmark, Buy, reaffirmed 2026-05-07) and no consensus target price, there is no validated upside anchor to justify chasing the stock at $47.26, roughly 87% of its $29.25-$49.96 52-week range. The evidence is genuinely two-sided: gross margin recovered from 34.6% in Q1 to 44.0% in Q2 and 42.6% in Q3, net income swung from -$38.8 million to $90.0 million, Q3 operating cash flow of $195.3 million reversed the Q1 outflow of -$171.7 million, and the shares have outperformed the S&P 500 by 41.15 points over six months. Against that, Q3 operating margin of 8.58% and net margin of 5.65% remain below the year-ago Q3 operating margin of 10.8%, trailing net margin is just 1.91%, ROE is 2.95%, and interest expense tripled to $19.4 million from $5.7 million, so HNI has recovered toward, not beyond, prior profitability. Supporting the Hold: P/S of 0.72x and P/B of 1.11x sit at or below the bottom of multi-year bands (P/S ~1.7x-3.8x, P/B ~1.2x-3.0x), EV/EBITDA of 14.86x is mid-range for the sector, the 3.09% dividend yield is above the furnishings norm, and the lone analyst's $6.73 average EPS estimate (tight $6.63-$6.82 range) implies a forward multiple near 7x on $47.26 — cheap if the margin recovery holds, but the 37.68x trailing PE is distorted by $0.027 trailing EPS and the -0.61 forward PE field is not economically meaningful. The biggest risks that would invalidate the thesis are a rollback of gross margin toward the 34.6% Q1 level, a failure to convert Q3's $168.9 million free cash flow into a positive trailing FCF figure, and a commercial-furniture or housing-driven hearth demand stall; this Hold would upgrade to Buy on two consecutive quarters of gross margin at or above 42% with trailing FCF turning positive and debt-to-equity falling below 0.75, and would downgrade to Sell on a gross margin break below 38% or a dividend cut. Verdict: fairly valued to modestly undervalued on sales and book, but the discount is a rational re-rating of a larger, more levered, lower-ROE business rather than a clean mispricing — a data-driven Hold, not personalized financial advice.
Sign up to view all
HNI 12-Month Price Forecast
The forward view is genuinely balanced: HNI has executed a sharp sequential recovery, with Q3 free cash flow of $168.9 million reversing the Q1 outflow of -$171.7 million, and the stock still trades at 0.72x sales and 1.11x book against historical bands roughly two to five times higher. But the business is growing revenue only 1.33% year over year, trailing net margin is 1.91%, ROE is 2.95%, and the 0.89 debt-to-equity with a 116% payout ratio means the dividend is not covered by trailing cash flow — so the low multiples are a rational re-rating, not a clean discount. With one analyst, a tight $6.63-$6.82 EPS range and no consensus target, there is no external validation to lean on, and the stock's 40.61% six-month run leaves it near the $49-50 resistance that has capped it repeatedly. I would upgrade to bullish if gross margin holds at or above 42% for two more quarters while trailing FCF turns positive and debt-to-equity falls below 0.75; I would downgrade to bearish on a gross margin break below 38%, a dividend cut, or a loss of the lone Buy rating.
Wall Street consensus
Coverage is extremely thin: only 1 analyst provides estimates, with an average estimated EPS of $6.73 (range $6.63 to $6.82) and average estimated revenue of $7.434 billion (range $7.355 billion to $7.511 billion). No consensus target price or Buy/Hold/Sell distribution is provided in the data, so implied upside to a consensus target cannot be calculated; the institutional ratings history shows only Benchmark maintaining a Buy rating (most recently reaffirmed 2026-05-07) and Sidoti & Co. having moved to Buy from Neutral back in March 2023, with no recent downgrades or upgrades. The signal is therefore weakly positive but statistically fragile — a single Buy rating from a long-standing bull is not a consensus. The absence of a target range means we cannot assess what the high and low cases assume; the estimated EPS range of $6.63-$6.82 is tight (roughly 3% spread), which implies the one covering analyst has high conviction in a narrow earnings outcome, but that is a single data point rather than a distribution of views. Insufficient analyst coverage is itself an analytical finding: HNI is a small-cap ($2.04 billion market cap per the metrics data, though the identity record shows $3.59 billion — a discrepancy worth flagging) with limited institutional sponsorship, which historically correlates with higher volatility, wider bid-ask spreads and less efficient price discovery. Investors should treat the lone Buy rating as directional color rather than a validated consensus, and weight the company's own margin trajectory and deleveraging progress more heavily than the sparse sell-side signal.
Drowning in data?
Find the real signal!
Bulls vs Bears: HNI Investment Factors
The bull case currently has the stronger near-term evidence: a genuine margin inflection (gross margin 34.6% to 42.6%, net income -$38.8 million to $90.0 million), 41.15 points of six-month relative strength, and P/S and P/B at the low end of multi-year ranges. The bear case is structural rather than cyclical: 0.89 debt-to-equity, -$70.1 million trailing FCF, a 116% payout ratio, and revenue growth of just 1.33% mean the re-rating is built on cost recovery rather than a growing business. The single most important tension is whether Q3's margin and cash-flow recovery is durable — if gross margin holds near 42-43% and FCF stays positive through the next two quarters, the low multiples look like a discount; if margins roll back toward the 34.6% Q1 level, the stock's 87%-of-range position leaves little cushion. Valuation is cheap on sales and book but justified by a 1.91% net margin and a more levered, lower-ROE business post-acquisition, so the debate is really about earnings quality, not headline multiples.
Bullish
- Sharp sequential margin recovery: Gross margin climbed from 34.6% in Q1 to 44.0% in Q2 and 42.6% in Q3, while net income swung from -$38.8 million to $51.1 million and then $90.0 million. Q3 EPS of $1.23 versus a Q1 loss of -$0.55 shows operating leverage is real once volume and cost absorption normalize.
- Strong six-month relative strength: The stock is up 40.61% over six months versus a -0.54% S&P 500 move, a relative strength spread of 41.15 points, and up 18.80% over one year against the index's 9.59%. This is company-specific re-rating, not beta-driven, and the shares sit at roughly 87% of the $29.25-$49.96 52-week range.
- Low absolute valuation multiples: P/S of 0.72x and P/B of 1.11x sit at or below the bottom of HNI's multi-year bands (P/S historically ~1.7x-3.8x, P/B ~1.2x-3.0x), while EV/EBITDA of 14.86x is mid-range for the sector. The market is pricing skepticism on margin durability and leverage rather than optimism.
- Q3 cash generation inflected positive: Q3 operating cash flow of $195.3 million and free cash flow of $168.9 million sharply reversed the Q1 operating outflow of -$171.7 million. If that cash cadence holds, the trailing -$70.1 million FCF deficit and the 116% payout ratio become bridgeable rather than structural.
Bearish
- Leverage and negative trailing FCF: Debt-to-equity of 0.89 and trailing free cash flow of -$70.1 million reflect the acquisition-funded balance sheet, with shares outstanding jumping from roughly 52.4 million to 72.3 million. Interest expense rose to $19.4 million in Q3 from $5.7 million a year earlier, a direct drag on earnings.
- Dividend not covered by cash flow: The 116% payout ratio against trailing free cash flow means the 3.09% yield is currently funded by something other than organic cash generation. A sustained FCF deficit would force a choice between the dividend, deleveraging, and capex.
- Barely growing top line: Q3 revenue of $1.593 billion grew only 1.33% year over year, and the Workplace Furnishings segment (~$1.418 billion) dwarfs Residential Building Products ($175 million), tying the company to soft commercial office demand. The thesis rests on margin recovery, not revenue acceleration, which caps the rational multiple.
- Profitability still below prior year: Q3 operating margin of 8.58% and net margin of 5.65% remain below the year-ago Q3 operating margin of 10.8%, and trailing net margin is just 1.91% with ROE of 2.95%. HNI has recovered toward, not beyond, its prior profitability, leaving the durability of the snap-back unproven.
HNI Technical Analysis
HNI is in a powerful, sustained uptrend that has carried the stock from a May 2026 trough near $29.25 to a current price of $47.26, a gain of 18.80% over the trailing year and 40.61% over six months. Against a 52-week range that spans roughly $29.25 to $49.96, the stock is trading at approximately 87% of its range — near the upper end but not at the extreme high — which signals persistent momentum rather than a washed-out value setup, though it also leaves limited headroom before resistance. The stock has decisively outperformed the S&P 500, with relative strength of 9.21 percentage points over one year and a striking 41.15 points over six months, confirming that the move is company-specific rather than a beta-driven rally. Short-term momentum is more mixed: the stock is up 1.68% over the past month versus a 4.99% decline for the S&P 500 (relative strength +6.67 points), but down 4.91% over three months, essentially flat versus the index's -4.91% (relative strength 0.0005). This divergence — a strong one-year and six-month trend against a flat-to-negative three-month stretch — points to a consolidation phase following the summer surge, with the recent 1-month bounce suggesting buyers are re-engaging after the September-October pullback toward the $45-46 area. The most recent session saw a 2.17% decline to $47.26 on volume of roughly 652,000 shares, a modest give-back within the consolidation rather than a trend break. Key support sits at the October swing low around $45.06 and, more significantly, the 52-week low near $29.25; resistance is defined by the 52-week high of $49.96, with the stock having repeatedly failed in the $49-50 zone in late August and again in early November. A breakout above $50 would signal a resumption of the primary uptrend and likely open a new leg higher, while a breakdown below $45 would suggest the multi-month consolidation is resolving lower and put the $40-42 summer breakout zone in play. With a maximum drawdown of -44.34% over the measured period, the stock has demonstrated meaningful downside volatility despite its recent strength, and the absence of a reported beta means position sizing should lean on this realized drawdown rather than a market-relative volatility estimate.
Beta
—
—
Max Drawdown
-44.3%
Largest decline past year
52-Week Range
—
Price range past year
Annual Return
+24.1%
Cumulative gain past year
| Period | HNI Return | S&P 500 |
|---|---|---|
| 1m | +3.7% | -2.4% |
| 3m | -0.7% | -2.3% |
| 6m | +63.9% | +2.8% |
| 1y | +24.1% | +11.3% |
| ytd | +15.1% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HNI Fundamental Analysis
Revenue is growing but only modestly: Q3 2026 revenue of $1.593 billion rose 1.33% year over year, and the multi-quarter progression shows $1.348 billion in Q1, $1.472 billion in Q2 and $1.593 billion in Q3 — a clear sequential build but a tepid top-line trajectory. The segment mix explains the dynamic: Workplace Furnishings at roughly $1.418 billion dwarfs Residential Building Products at $175 million, meaning overall growth is hostage to commercial office demand while the smaller hearth business adds housing-cycle cyclicality. The 1.33% YoY growth implies the investment case is not about revenue acceleration but about margin recovery and operating leverage on a largely flat sales base — a distinction that matters because it caps the multiple the market should rationally pay. Profitability has inflected sharply: after a Q1 net loss of -$38.8 million and EPS of -$0.55, HNI earned $51.1 million in Q2 and $90.0 million in Q3, with Q3 EPS of $1.23 and gross margin expanding from 34.6% in Q1 to 44.0% in Q2 and 42.6% in Q3. The Q3 operating margin of 8.58% and net margin of 5.65% remain below the 10.8% operating margin posted in the year-ago Q3, and the trailing net margin of just 1.91% underscores how much of the fiscal year was dragged down by the first-quarter loss. The sequential margin snap-back is impressive, but the year-over-year comparison shows HNI has recovered toward, not beyond, its prior profitability — leaving room for further normalization but also exposing how sensitive results are to volume and cost absorption. The balance sheet is the key risk: debt-to-equity stands at 0.89, the current ratio is a serviceable 1.24, and trailing free cash flow is negative at -$70.1 million, driven by a Q1 operating cash outflow of -$171.7 million and Q2 capex of $62.4 million. Q3 was a strong cash quarter — operating cash flow of $195.3 million and free cash flow of $168.9 million — but the full-year FCF deficit and a payout ratio of 116% (dividend yield 3.09%) mean the dividend is not currently covered by trailing free cash flow, a yellow flag. ROE of just 2.95% is well below the company's historical mid-single-digit to low-double-digit range, reflecting the loss quarter and the enlarged equity base from acquisition-related share issuance (shares outstanding jumped from roughly 52.4 million to 72.3 million), so deleveraging and FCF restoration are the metrics to watch.
Quarterly Revenue
$1.6B
2026-10
Revenue YoY Growth
+132.9%
YoY Comparison
Gross Margin
42.6%
Latest Quarter
Free Cash Flow
$-70100000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HNI Overvalued?
Because trailing net income is positive but minimal (EPS of $0.027), the trailing PE of 37.68x is distorted and not the right anchor; the more informative metrics are the price-to-sales ratio of 0.72x, EV/EBITDA of 14.86x, and price-to-book of 1.11x. The forward PE field of -0.61 is not economically meaningful (a negative value driven by data construction), so we lean on EV/EBITDA and P/S, which frame HNI as a low-multiple, cyclical industrial rather than a growth compounder. The 0.72x P/S is strikingly low in absolute terms, but that reflects a business with a 1.9% net margin and 8.5% operating margin — thin profitability justifies a low sales multiple. Peer comparison is constrained because the provided valuation dataset contains no explicit industry-average multiples; on the metrics available, HNI's 1.11x book value and 0.72x sales sit at the low end of what a diversified furnishings and fixtures manufacturer typically commands, while the 14.86x EV/EBITDA is mid-range for the sector. The 3.09% dividend yield is well above the sector norm and provides a valuation floor argument, though the 116% payout ratio undermines confidence in its sustainability. Historical context is revealing: HNI's own PE history over the past several years has ranged from roughly 9.5x (Q3 2026) to over 37x (Q1 2025) and 55x (Q4 2021), and its P/S has ranged from about 1.7x to 3.8x. The current 0.72x P/S is at or below the bottom of that multi-year band, and the 1.11x P/B is likewise near the low end versus historical readings of 1.2x-3.0x — a configuration that suggests the market is pricing in skepticism about margin durability and balance-sheet risk rather than optimism. That said, the depressed multiples partly reflect the enlarged share count and debt from acquisition activity, so the apparent discount is not purely a value opportunity; it is a re-rating of a larger, more levered, lower-ROE business.
PE
37.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 4x~37x
vs. Industry Avg
24.3x
Industry PE ~24.3x*
EV/EBITDA
14.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the balance sheet and cash conversion. Debt-to-equity of 0.89, Q3 interest expense of $19.4 million (versus $5.7 million a year earlier), and trailing free cash flow of -$70.1 million show a company that funded acquisitions with debt and equity, with shares outstanding rising from roughly 52.4 million to 72.3 million. The 116% payout ratio means the 3.09% dividend is not covered by trailing FCF, and ROE of 2.95% is far below historical mid-single to low-double-digit levels. Revenue concentration compounds this: Workplace Furnishings at roughly $1.418 billion versus $175 million for Residential Building Products ties results to commercial office demand, and Q3 revenue growth of only 1.33% year over year means margin recovery, not volume, must carry the earnings story. Market and competitive risks are dominated by valuation compression and cyclicality. P/S of 0.72x and P/B of 1.11x are at multi-year lows, but that discount reflects a 1.91% net margin and a larger, more levered business rather than a pure mispricing, so a re-rating higher requires proof of durable margins. The stock has already run 40.61% in six months and sits at roughly 87% of its 52-week range, leaving limited headroom before the $49-50 resistance zone that has capped it repeatedly. With no reported beta, position sizing should lean on the -44.34% max drawdown, and the single-analyst coverage means price discovery is thin and headline-sensitive. The worst-case scenario is a commercial-furniture demand stall combined with a housing-driven hearth slowdown that pushes gross margin back toward the 34.6% Q1 level, reviving losses and forcing a dividend cut or dilutive deleveraging. In that chain, the stock could retrace toward the October swing low of $45.06 and, in a fuller de-rating, toward the 52-week low of $29.25 — roughly -38% from the current $47.26. A more moderate adverse case to the $40-42 summer breakout zone implies a -11% to -15% drawdown, consistent with the stock's demonstrated -44.34% maximum drawdown.
FAQ
The risk/reward is balanced rather than compelling at $47.26. On the positive side, the stock trades at 0.72x sales and 1.11x book, well below its historical bands, pays a 3.09% dividend, and the lone analyst's $6.73 EPS estimate implies roughly 7x forward earnings; gross margin recovered from 34.6% in Q1 to 42.6% in Q3 and Q3 free cash flow of $168.9 million reversed the Q1 outflow of -$171.7 million. On the negative side, revenue grew just 1.33% year over year, trailing free cash flow is -$70.1 million, the payout ratio is 116%, debt-to-equity is 0.89 and interest expense tripled to $19.4 million, while the shares have already run 40.61% in six months and sit near the $49-50 resistance that has capped them repeatedly. There is also no consensus target to anchor upside, since only one analyst covers the name. It is a reasonable buy for value- and income-oriented investors who can tolerate a 12-24 month holding period and size positions around the -44.34% maximum drawdown, but it is not attractive for momentum buyers chasing at 87% of the 52-week range.